Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-22-082217
Filing Date
2022-12-22
Accepted
2022-12-22 16:30:52
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_citiuspharma.htm   iXBRL 10-K 1082473
2 DESCRIPTION OF COMMON STOCK f10k2022ex4-25_citiuspharma.htm EX-4.25 4470
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM f10k2022ex23-1_citiuspharma.htm EX-23.1 1857
4 CERTIFICATION f10k2022ex31-1_citiuspharma.htm EX-31.1 10751
5 CERTIFICATION f10k2022ex31-2_citiuspharma.htm EX-31.2 10653
6 CERTIFICATION f10k2022ex32-1_citiuspharma.htm EX-32.1 5303
  Complete submission text file 0001213900-22-082217.txt   4586451

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ctxr-20220930.xsd EX-101.SCH 59617
8 XBRL CALCULATION FILE ctxr-20220930_cal.xml EX-101.CAL 35418
9 XBRL DEFINITION FILE ctxr-20220930_def.xml EX-101.DEF 207903
10 XBRL LABEL FILE ctxr-20220930_lab.xml EX-101.LAB 457455
11 XBRL PRESENTATION FILE ctxr-20220930_pre.xml EX-101.PRE 221659
55 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_citiuspharma_htm.xml XML 354660
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-38174 | Film No.: 221482317
SIC: 2834 Pharmaceutical Preparations